SCHEMBL4501619

SCHEMBL4501619

CNCc1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.43
MAOB P27338 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
TGM2 P21980 1/20 0.37
NAMPT P43490 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
AURKB Q96GD4 2/20 0.36
AURKA O14965 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
KDR P35968 1/20 0.36
FLT3 P36888 1/20 0.36
AURKC Q9UQB9 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501618 1.00 BACE1 (0.43) BACE1MAOBNPC1RAB9APOLB
SCHEMBL4482547 0.90 BACE1 (0.41) BACE1TGM2TP53MAPTSMN1; SMN2
SCHEMBL4482552 0.90 BACE1 (0.41) BACE1TGM2TP53MAPTSMN1; SMN2
SCHEMBL4494324 0.89 BACE1 (0.39) BACE1MAOBNPC1RAB9APOLB
SCHEMBL4494331 0.89 BACE1 (0.39) BACE1MAOBNPC1RAB9APOLB
SCHEMBL4490752 0.89 CCNB2 (0.37) BACE1MAOBTGM2TP53MAPT
SCHEMBL4490758 0.89 CCNB2 (0.37) BACE1MAOBTGM2TP53MAPT
SCHEMBL225345 0.89 BACE1 (0.42) BACE1TGM2ALDH1A1CASP3PPARG
SCHEMBL225346 0.89 BACE1 (0.42) BACE1TGM2ALDH1A1CASP3PPARG
SCHEMBL2571982 0.88 BACE1 (0.41) BACE1NPC1RAB9APOLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885MAOB 668/4885NPC1 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.